NantHealth, Inc.
NHIQ
$0.0001
$0.000.00%
| Weiss Ratings | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 35.63 | |||
| Price History | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -96.88% | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -95.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -99.97% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -100.00% | |||
| 52-Week Low % Change | 9,900.00% | |||
| Price | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.17 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Dec 13, 2024 | |||
| 52-Week High Price (Date) | May 02, 2024 | |||
| Valuation | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.26K | |||
| Enterprise Value | 270.81M | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -8.26 | |||
| Earnings Per Share Growth | 8.12% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 4.21 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -9.07 | |||
| Enterprise Value/EBIT | -6.96 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 15.01M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 855 949 6268 | |||
| Address | 3000 RDU Center Drive Morrisville, NC 27560 | |||
| Website | nanthealth.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -60.57% | |||
| Profit Margin | -109.49% | |||
| Management Effectiveness | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -15.83% | |||
| Return on Equity | -- | |||
| Income Statement | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 64.27M | |||
| Total Revenue (TTM) | 64.27M | |||
| Revenue Per Share | $4.28 | |||
| Gross Profit (TTM) | 40.90M | |||
| EBITDA (TTM) | -29.87M | |||
| EBIT (TTM) | -38.93M | |||
| Net Income (TTM) | -70.37M | |||
| Net Income Avl. to Common (TTM) | -70.37M | |||
| Total Revenue Growth (Q YOY) | -25.04% | |||
| Earnings Growth (Q YOY) | -9.74% | |||
| EPS Diluted (TTM) | -8.26 | |||
| EPS Diluted Growth (Q YOY) | 43.68% | |||
| Balance Sheet | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.82M | |||
| Cash Per Share (Q) | $0.39 | |||
| Total Current Assets (Q) | 15.34M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -250.18M | |||
| Current Ratio (Q) | 0.080 | |||
| Book Value Per Share (Q) | -$9.11 | |||
| Total Assets (Q) | 146.48M | |||
| Total Current Liabilities (Q) | 191.09M | |||
| Total Debt (Q) | 276.63M | |||
| Total Liabilities (Q) | 396.66M | |||
| Total Common Equity (Q) | -250.18M | |||
| Cash Flow | NHIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -4.38M | |||
| Cash from Financing (TTM) | 38.12M | |||
| Net Change in Cash (TTM) | 5.24M | |||
| Levered Free Cash Flow (TTM) | -16.45M | |||
| Cash from Operations (TTM) | -27.64M | |||
